Healius (ASX:HLS) Ending Cash Position: A$52 Mil (As of Dec. 2025)


ASX:HLS Healius Ltd ASX:HLS
54 GF Score
Price A$0.39
GF Value A$1.02
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius Ending Cash Position?

Healius ASX:HLS -1.28% 54 Ending Cash Position is A$52 Mil as of Dec. 2025. GuruFocus rates ASX:HLS with a GF Score™ of 54/100 and a GF Value™ of A$1.02 (Possible Value Trap). The stock has 7 warning signs investors should review.

Healius's Ending Cash Position for the quarter that ended in Dec. 2025 was A$52 Mil.

Healius's quarterly Ending Cash Position declined from Dec. 2024 (A$116 Mil) to Jun. 2025 (A$57 Mil) and declined from Jun. 2025 (A$57 Mil) to Dec. 2025 (A$52 Mil).

Healius's annual Ending Cash Position declined from Jun. 2023 (A$115 Mil) to Jun. 2024 (A$60 Mil) and declined from Jun. 2024 (A$60 Mil) to Jun. 2025 (A$57 Mil).

Healius Ending Cash Position Related Terms

Healius Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Healius's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healius Ending Cash Position Chart

Healius Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.70 81.30 115.30 60.10 57.20

Healius Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.70 60.10 116.30 57.20 51.60
ASX:HLS
54GF Score
Healius Ltd ASX:HLS
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healius Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Healius's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=60.1+-2.9
=57

Healius's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=57.2+-5.6
=52

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of A$52 Mil mean?
Healius (ASX:HLS) has a Ending Cash Position of A$52 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Healius and its competitors.
Is Healius' Ending Cash Position too high?
Healius' current Ending Cash Position is A$52 Mil. Overall, Healius has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healius' Ending Cash Position compare to TMO and DHR?
Healius' Ending Cash Position of A$52 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Diagnostics & Research company?
A good Ending Cash Position depends on the Medical Diagnostics & Research industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Healius and its competitors. Healius's current Ending Cash Position is A$52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Based on GuruFocus' analysis, Healius (ASX:HLS) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.02, compared to a current price of A$0.39 — trading 62.3% below its estimated fair value. The current Ending Cash Position is A$52 Mil. Healius' overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Healius (ASX:HLS), the current Ending Cash Position is A$52 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healius (ASX:HLS) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of A$0.39 is trading 62.3% below its estimated GF Value™ of A$1.02. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for ASX:HLS:

  • Ending Cash Position: A$52 Mil
  • GF Value™: A$1.02 vs. price of A$0.39 (62.3% below fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the ASX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healius Business Description

Other Exchanges PGZ:Germany
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
54GF Score

Get the complete analysis for ASX:HLS

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.39
Price
A$1.02
GF Value